Ambrx Closes $200 million in Crossover Financing with Leading Healthcare Investors to Advance its Clinical and Preclinical Pipeline of Precision Biologics
GentiBio Expands Leadership Team and Partnership with MIGAL to Help Advance Development of Engineered Regulatory T Cell Therapies
AbSci CEO Sean McClain Named as an Entrepreneur Of The Year® 2020 Pacific Northwest Region Award Winner
Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines